Net income attributable to the Group: €2,983 millionRecommended ordinary dividend: €14 per share “In a trying year for the group, we strengthened our organization and took significant steps to further ...
ROCKVILLE, Md., April 03, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results